13G Filing: Great Point Partners and Newlink Genetics Corp (NLNK)

Page 2 of 10

Page 2 of 10 – SEC Filing

CUSIP
No.  651511107
13G Page
2 of 9 Pages
1.

NAMES OF REPORTING PERSONS

Great Point Partners, LLC

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):

37-1475292

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
3. SEC USE ONLY
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING PERSON

WITH
5.

SOLE VOTING POWER

0

6.

SHARED VOTING POWER

1,500,000

7.

SOLE DISPOSITIVE POWER

0

8.

SHARED DISPOSITIVE POWER

1,500,000

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,500,000

10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) o
11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.13%1

12.

TYPE OF REPORTING PERSON (See Instructions)

IA

1 Based on a total of 29,225,682 shares outstanding, as reported by the Issuer on a Form 10Q filed with the SEC on May 5, 2017.

Follow Lumos Pharma Inc. (NASDAQ:(LUMO))

Page 2 of 10